Gene · 4303
Papers2,706
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,706
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNAs as the critical regulators of Forkhead box protein family during gynecological and breast tumor progression and metastasis. | Eur J Med Res | 2023 | 37689738 | PubTator, text mining | PubMed |
| FoxO3 Modulates Circadian Rhythms in Neural Stem Cells. | Int J Mol Sci | 2023 | 37686468 | PubTator, text mining | PubMed |
| FOXM1, MEK, and CDK4/6: New Targets for Malignant Peripheral Nerve Sheath Tumor Therapy. | Int J Mol Sci | 2023 | 37686402 | PubTator, text mining | PubMed |
| In vitro-generated human muscle reserve cells are heterogeneous for Pax7 with distinct molecular states and metabolic profiles. | Stem Cell Res Ther | 2023 | 37679820 | PubTator, text mining | PubMed |
| A systematic review and meta-analysis of the SIRT1 response to exercise. | Sci Rep | 2023 | 37679377 | PubTator, text mining | PubMed |
| Hypoxia-associated genetic signature in ovarian steroid cell tumor NOS. | Endocr Relat Cancer | 2023 | 37655726 | PubTator, text mining | PubMed |
| Towards understandings of serine/arginine-rich splicing factors. | Acta Pharm Sin B | 2023 | 37655328 | PubTator, text mining | PubMed |
| Research progress on the role of lncRNA-miRNA networks in regulating adipogenic and osteogenic differentiation of bone marrow mesenchymal stem cells in osteoporosis. | Front Endocrinol (Lausanne) | 2023 | 37645421 | PubTator, text mining | PubMed |
| Sex-biased genome-editing effects of CRISPR-Cas9 across cancer cells dependent on p53 status. | iScience | 2023 | 37636042 | PubTator, text mining | PubMed |
| Natural and Synthetic Anticancer Epidrugs Targeting the Epigenetic Integrator UHRF1. | Molecules | 2023 | 37630248 | PubTator, text mining | PubMed |
| Role of Circular RNAs in Atherosclerosis through Regulation of Inflammation, Cell Proliferation, Migration, and Apoptosis: Focus on Atherosclerotic Cerebrovascular Disease. | Medicina (Kaunas) | 2023 | 37629751 | PubTator, text mining | PubMed |
| AMPK/FOXO3a Pathway Increases Activity and/or Expression of ATM, DNA-PKcs, Src, EGFR, PDK1, and SOD2 and Induces Radioresistance under Nutrient Starvation. | Int J Mol Sci | 2023 | 37629008 | PubTator, text mining | PubMed |
| Unraveling the Role of EV-Derived miR-150-5p in Prostate Cancer Metastasis and Its Association with High-Grade Gleason Scores: Implications for Diagnosis. | Cancers (Basel) | 2023 | 37627176 | PubTator, text mining | PubMed |
| Integration of phytotherapy and chemotherapy: Recent advances in anticancer molecular pathways. | Iran J Basic Med Sci | 2023 | 37605725 | PubTator, text mining | PubMed |
| Development of an interfering peptide M1-20 with potent anti-cancer effects by targeting FOXM1. | Cell Death Dis | 2023 | 37598210 | PubTator, text mining | PubMed |
| Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. | Arch Toxicol | 2023 | 37597078 | PubTator, text mining | PubMed |
| Targeting FoxO proteins induces lytic reactivation of KSHV for treating herpesviral primary effusion lymphoma. | PLoS Pathog | 2023 | 37594999 | PubTator, text mining | PubMed |
| Innovative therapeutic strategies for cardiovascular disease. | EXCLI J | 2023 | 37593239 | PubTator, text mining | PubMed |
| FOXO1 promotes the expression of canonical WNT target genes in examined basal-like breast and glioblastoma multiforme cancer cells. | FEBS Open Bio | 2023 | 37584250 | PubTator, text mining | PubMed |
| The APC/C E3 ligase subunit ANAPC11 mediates FOXO3 protein degradation to promote cell proliferation and lymph node metastasis in urothelial bladder cancer. | Cell Death Dis | 2023 | 37573356 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4303/papers?page=11